Suppliers, peptides and research in the UK, US, Australia and Europe. Every record is checked by a person and dated.
BPC-157, GHK-Cu, KPV and 1 more
CJC-1295, Ipamorelin, Sermorelin and 1 more
5-amino-1MQ, Cagrilintide, MOTS-c and 6 more
Pinealon, Selank, Semax
GHK-Cu, Glutathione
Epitalon, FOXO4-DRI, Glutathione and 4 more
KPV, Thymogen, Thymosin alpha-1 and 1 more
Ranked by published human clinical trials on PubMed, with completed trials registered on ClinicalTrials.gov alongside. A count of research, not a measure of how well anything works.
Studied for body weight in overweight and obesity (phase 3)
Studied for body weight in obesity (phase 3, 2,539 people)
Studied for sepsis (phase 3, 1,106 people, no significant benefit)
Studied for raising the body's glutathione stores (randomised, 54 adults)
Studied for growth hormone deficiency in children (randomised, 43 children)
Studied for raising NAD+ levels via oral precursors (systematic review and trials)
Counts trials of the precursors nicotinamide riboside and NMN.
Studied for pulmonary hypertension (inhaled, n=20)
Studied for visceral fat in HIV-associated lipodystrophy (human trials)
Studied for Barth syndrome (open-label extension, n=10; case report)
Studied for body weight with semaglutide (two phase 3 trials)
The peptides most often listed. Each label opens that peptide’s page for the country.
Peptide supply companies in the UK, US, Australia and Europe. Filter by country, see what each stocks and on what terms.
Browse →One page per peptide. What it is, what it has been studied for, its regulatory status, and who stocks it.
Browse →Peer-reviewed papers, summarised plainly and labelled by study type so you can tell a rat study from a human trial.
Browse →Compounding pharmacies in the US, UK, Australia and Europe: their licences, who they supply, and any public regulator record.
Browse →